Evidence map›Paper›PMID 34492381›Full record

ArticleClinical immunology (Orlando, Fla.)2021

The interaction of anti-DNA antibodies with DNA antigen: Evidence for hysteresis for high avidity binding.

David S Pisetsky, Robert Shaffer, Dustin D Armstrong, Diane M Spencer

Abstract read
In one paragraph

Article in Clinical immunology (Orlando, Fla.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David S PisetskyMedical Research Service, Durham Veterans Administration Medical Center, Durham, NC 27705, USA; Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: david.pisetsky@duke.edu.
Robert ShafferEnable Therapeutics, LLC, Framingham, MA 01701, USA.
Dustin D ArmstrongEnable Therapeutics, LLC, Framingham, MA 01701, USA.
Diane M SpencerDivision of Rheumatology and Immunology, Duke University Medical Center, Durham, NC 27710, USA.

Funding

Engineering Polymers to Scavenge DAMPs in Arthritis and LupusR01AR073935 · NIAMS · DUKE UNIVERSITY · PI LEONG, KAM W, SULLENGER, BRUCE ALAN · 2018 to 2022
$3.3M
MECHANISMS OF AUTOIMMUNITY IN SLEI01BX001056 · VA · DURHAM VA MEDICAL CENTER · PI PISETSKY, DAVID STEPHEN · 2011 to 2014
–
BLRD VA I01 BX001056NIAMS NIH HHS R01 AR073935
6 · The paper itself

Abstract

Antibodies to DNA (anti-DNA) are the serological hallmark of systemic lupus erythematosus. Previous studies have indicated that the phosphodiester backbone is the main antigenic target, with electrostatic interactions important for high avidity. To define further these interactions, the effects of ionic strength on anti-DNA binding of SLE plasmas were assessed in association and dissociation assays by ELISA. As these studies demonstrated, increasing ionic strength to a concentration of 1000 mM NaCl reduced antibody binding although the extent of the reduction varied among samples. In dissociation assays, differences among plasmas were also observed. For one of the plasmas, binding to DNA displayed resistance to dissociation by increasing ionic strength even though these concentrations limited binding in association assays. Time course studies showed a gradual change in binding interactions. These studies indicate that anti-DNA binding can involve both electrostatic and non-electrostatic interactions, with binding in some plasmas showing evidence of hysteresis.

Indexed as

Antibodies, AntinuclearAntibody AffinityAntigen-Antibody ComplexAutoantigensDNAHumansLupus Erythematosus, SystemicOsmolar ConcentrationAntibodies, AntinuclearAntigen-Antibody ComplexAutoantigensDNAAnti-DNA antibodiesAvidityChaotropic agentsDNAElectrostatic interactionsHysteresisSystemic lupus erythematosus

Identifiers

PMID34492381
PMCPMC8565600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.